中国循证心血管医学杂志
中國循證心血管醫學雜誌
중국순증심혈관의학잡지
Chinese Journal of Evidence-Bases Cardiovascular Medicine
2015年
5期
666-668,671
,共4页
周维伟%赵冰%刘淑满%杨春霞
週維偉%趙冰%劉淑滿%楊春霞
주유위%조빙%류숙만%양춘하
曲美他嗪%PCI%心肌保护%TIMI帧数
麯美他嗪%PCI%心肌保護%TIMI幀數
곡미타진%PCI%심기보호%TIMI정수
Trimetazidine%Percutaneous coronary intervention%Myocardial protection%TIMI frame count
目的:评估曲美他嗪对不稳定型心绞痛患者经皮冠状动脉介入治疗(PCI)围术期的影响。方法选取2013年12月~2014年11月顺义区医院住院并行冠状动脉介入治疗的不稳定型心绞痛患者79例,其中男性52例,女性27例,平均年龄(59.3±9.4)岁。入选者随机分为常规治疗组(40例)和曲美他嗪组(39例)。常规治疗组给予阿司匹林、硫酸氢氯吡格雷、他汀类等药物治疗,曲美他嗪组在常规药物治疗的基础上于PCI术前3 d口服曲美他嗪20 mg,3/日,术后继续服用。所有患者均于PCI术前、术后24h检测肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)和心肌肌钙蛋白T(cTnT)变化情况。比较两组临床疗效。采用TIMI帧数(TFC)评估冠状动脉血流改善情况。结果常规治疗组PCI术后较术前CK、CK-MB和cTnT浓度升高,差异有统计学意义(P均<0.05)。与常规治疗组术后比较,曲美他嗪组CK、CK-MB和cTNT均降低,(102.52±30.40)U/Lvs.(82.37±22.40)U/L、(19.52±3.49)U/Lvs.(14.37±2.68)U/L、(0.13±0.12) ng/mlvs.(0.05±0.08)ng/ml,差异有统计学意义(P均<0.05)。常规治疗组临床显效16例(40.0%),有效14例(35.0%),总有效率为75.0%;曲美他嗪组临床显效26例(66.7%),有效9例(23.1%),总有效率为89.7%,两组临床总有效率比较差异有统计学意义(P<0.05)。曲美他嗪组前降支和回旋支的平均TFC值明显低于常规治疗组,差异具有统计学意义(P均<0.05)。结论曲美他嗪可以抑制PCI围术期相关心肌损伤,且对冠状动脉血流储备具有较好的改善作用。
目的:評估麯美他嗪對不穩定型心絞痛患者經皮冠狀動脈介入治療(PCI)圍術期的影響。方法選取2013年12月~2014年11月順義區醫院住院併行冠狀動脈介入治療的不穩定型心絞痛患者79例,其中男性52例,女性27例,平均年齡(59.3±9.4)歲。入選者隨機分為常規治療組(40例)和麯美他嗪組(39例)。常規治療組給予阿司匹林、硫痠氫氯吡格雷、他汀類等藥物治療,麯美他嗪組在常規藥物治療的基礎上于PCI術前3 d口服麯美他嗪20 mg,3/日,術後繼續服用。所有患者均于PCI術前、術後24h檢測肌痠激酶(CK)、肌痠激酶同工酶(CK-MB)和心肌肌鈣蛋白T(cTnT)變化情況。比較兩組臨床療效。採用TIMI幀數(TFC)評估冠狀動脈血流改善情況。結果常規治療組PCI術後較術前CK、CK-MB和cTnT濃度升高,差異有統計學意義(P均<0.05)。與常規治療組術後比較,麯美他嗪組CK、CK-MB和cTNT均降低,(102.52±30.40)U/Lvs.(82.37±22.40)U/L、(19.52±3.49)U/Lvs.(14.37±2.68)U/L、(0.13±0.12) ng/mlvs.(0.05±0.08)ng/ml,差異有統計學意義(P均<0.05)。常規治療組臨床顯效16例(40.0%),有效14例(35.0%),總有效率為75.0%;麯美他嗪組臨床顯效26例(66.7%),有效9例(23.1%),總有效率為89.7%,兩組臨床總有效率比較差異有統計學意義(P<0.05)。麯美他嗪組前降支和迴鏇支的平均TFC值明顯低于常規治療組,差異具有統計學意義(P均<0.05)。結論麯美他嗪可以抑製PCI圍術期相關心肌損傷,且對冠狀動脈血流儲備具有較好的改善作用。
목적:평고곡미타진대불은정형심교통환자경피관상동맥개입치료(PCI)위술기적영향。방법선취2013년12월~2014년11월순의구의원주원병행관상동맥개입치료적불은정형심교통환자79례,기중남성52례,녀성27례,평균년령(59.3±9.4)세。입선자수궤분위상규치료조(40례)화곡미타진조(39례)。상규치료조급여아사필림、류산경록필격뢰、타정류등약물치료,곡미타진조재상규약물치료적기출상우PCI술전3 d구복곡미타진20 mg,3/일,술후계속복용。소유환자균우PCI술전、술후24h검측기산격매(CK)、기산격매동공매(CK-MB)화심기기개단백T(cTnT)변화정황。비교량조림상료효。채용TIMI정수(TFC)평고관상동맥혈류개선정황。결과상규치료조PCI술후교술전CK、CK-MB화cTnT농도승고,차이유통계학의의(P균<0.05)。여상규치료조술후비교,곡미타진조CK、CK-MB화cTNT균강저,(102.52±30.40)U/Lvs.(82.37±22.40)U/L、(19.52±3.49)U/Lvs.(14.37±2.68)U/L、(0.13±0.12) ng/mlvs.(0.05±0.08)ng/ml,차이유통계학의의(P균<0.05)。상규치료조림상현효16례(40.0%),유효14례(35.0%),총유효솔위75.0%;곡미타진조림상현효26례(66.7%),유효9례(23.1%),총유효솔위89.7%,량조림상총유효솔비교차이유통계학의의(P<0.05)。곡미타진조전강지화회선지적평균TFC치명현저우상규치료조,차이구유통계학의의(P균<0.05)。결론곡미타진가이억제PCI위술기상관심기손상,차대관상동맥혈류저비구유교호적개선작용。
Objective To review the influence of trimetazidine during percutaneous coronary intervention (PCI) in patients with unstable angina pectoris (UAP).Methods UAP patients (n=79, male 52, female 27 and average age=59.3±9.4) were chosen from Dec. 2013 to Nov. 2014. The patients were randomly divided into routine group (n=40) and trimetazidine group (n=39). The routine group was treated with aspirin, clopidogrel and statins, and trimetazidine group additionally with trimetazidine orally (20 mg, 3 times a day) 3 d before PCI and continuously after PCI. The changes of creatine kinase (CK), creatine kinase MB (CK-MB) and cardiac troponin T (cTnT) were detected in all patients before and 24 h after PCI. The curative effects were compared between 2 groups, and improvement of coronary artery flow was reviewed by using TIMI frame count (TFC).Results The levels of CK, CK-MB and cTnT increased in routine group after PCI (allP<0.05). Compared with routine group after PCI, the levels of CK [(102.52±30.40) U/Lvs. (82.37±22.40) U/L], CK-MB [(19.52±3.49) U/Lvs. (14.37±2.68) U/L] and cTnT [(0.13±0.12) ng/mLvs. (0.05±0.08) ng/mL] decreased in trimetazidine group (allP<0.05). There were 16 cases (40%) with obvious curative effect, 14 (35%) with curative effect and the total effective rate was 75.0% in routine group. There were 26 cases (66.7%) with obvious curative effect, 9 (23.1%) with curative effect and the total effective rate was 89.7% in trimetazidine group (P<0.05). The average TFC values of anterior descending branch and circumflex branch or coronary artery were significantly lower in trimetazidine group than those in routine group (allP<0.05).Conclusion Trimetazidine can inhibit perioperative myocardial injury correlated to PCI, and improve coronary flow reserve.